Tyche Industries Limited (BOM:532384)
104.53
+0.95 (0.92%)
At close: Nov 17, 2026
Tyche Industries Revenue
Tyche Industries had revenue of 161.29M INR in the quarter ending September 30, 2026, with 13.91% growth. This brings the company's total for the last twelve months to 503.78M, down -11.66% year-over-year. In the fiscal year ending March 31, 2026, Tyche Industries had annual revenue of 541.62M, down -18.21%. That makes Tyche Industries the 39,790th largest company in the world by revenue and 3,800th in India.
Revenue (ttm)
503.78M
Revenue Growth
-11.66%
P/S Ratio
2.11
Revenue / Employee
3.02M
Employees
167
Market Cap
1.07B
Revenue by Geography
- Export 484.13M 90.3%
- India 52.21M 9.7%
Fiscal year ended Mar 31, 2026 See the full Tyche Industries breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 541.62M | -120.60M | -18.21% |
| Mar 31, 2025 | 662.22M | -34.63M | -4.97% |
| Mar 31, 2024 | 696.84M | -59.16M | -7.83% |
| Mar 31, 2023 | 756.00M | 125.84M | 19.97% |
| Mar 31, 2022 | 630.16M | -163.86M | -20.64% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.08B |
| Kimia Biosciences | 1.04B |
| Accretion Nutraveda | 489.95M |
| Himalaya Nutravedics India | 430.68M |
| Auro Laboratories | 407.90M |